WST vs. ALGN
Compare and contrast key facts about West Pharmaceutical Services, Inc. (WST) and Align Technology, Inc. (ALGN).
Performance
WST vs. ALGN - Performance Comparison
Loading graphics...
WST vs. ALGN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
WST West Pharmaceutical Services, Inc. | -8.06% | -15.73% | -6.75% | 49.97% | -49.70% | 65.88% | 89.05% | 54.13% | -0.08% | 17.02% |
ALGN Align Technology, Inc. | 10.62% | -25.11% | -23.90% | 29.92% | -67.91% | 22.98% | 91.51% | 33.24% | -5.74% | 131.13% |
Fundamentals
WST:
$18.37B
ALGN:
$12.39B
WST:
$6.79
ALGN:
$5.68
WST:
37.23
ALGN:
30.42
WST:
5.98
ALGN:
3.09
WST:
5.79
ALGN:
3.06
WST:
$3.07B
ALGN:
$4.03B
WST:
$1.10B
ALGN:
$2.71B
WST:
$723.60M
ALGN:
$685.37M
Returns By Period
In the year-to-date period, WST achieves a -8.06% return, which is significantly lower than ALGN's 10.62% return. Over the past 10 years, WST has outperformed ALGN with an annualized return of 14.04%, while ALGN has yielded a comparatively lower 8.99% annualized return.
WST
- 1D
- 0.84%
- 1M
- 0.59%
- YTD
- -8.06%
- 6M
- -6.72%
- 1Y
- 15.20%
- 3Y*
- -9.74%
- 5Y*
- -2.11%
- 10Y*
- 14.04%
ALGN
- 1D
- 0.76%
- 1M
- -8.62%
- YTD
- 10.62%
- 6M
- 35.45%
- 1Y
- 9.27%
- 3Y*
- -19.74%
- 5Y*
- -20.53%
- 10Y*
- 8.99%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
WST vs. ALGN — Risk / Return Rank
WST
ALGN
WST vs. ALGN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for West Pharmaceutical Services, Inc. (WST) and Align Technology, Inc. (ALGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| WST | ALGN | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.37 | 0.17 | +0.20 |
Sortino ratioReturn per unit of downside risk | 0.94 | 0.59 | +0.35 |
Omega ratioGain probability vs. loss probability | 1.11 | 1.11 | 0.00 |
Calmar ratioReturn relative to maximum drawdown | 0.54 | 0.22 | +0.32 |
Martin ratioReturn relative to average drawdown | 1.11 | 0.38 | +0.72 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| WST | ALGN | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.37 | 0.17 | +0.20 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.05 | -0.42 | +0.36 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.41 | 0.18 | +0.23 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.37 | 0.16 | +0.21 |
Correlation
The correlation between WST and ALGN is 0.40, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
WST vs. ALGN - Dividend Comparison
WST's dividend yield for the trailing twelve months is around 0.34%, while ALGN has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
WST West Pharmaceutical Services, Inc. | 0.34% | 0.31% | 0.25% | 0.22% | 0.31% | 0.15% | 0.23% | 0.41% | 0.58% | 0.54% | 0.58% | 0.75% |
ALGN Align Technology, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
WST vs. ALGN - Drawdown Comparison
The maximum WST drawdown since its inception was -59.29%, smaller than the maximum ALGN drawdown of -92.30%. Use the drawdown chart below to compare losses from any high point for WST and ALGN.
Loading graphics...
Drawdown Indicators
| WST | ALGN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -59.29% | -92.30% | +33.01% |
Max Drawdown (1Y)Largest decline over 1 year | -24.70% | -39.73% | +15.03% |
Max Drawdown (5Y)Largest decline over 5 years | -59.29% | -82.89% | +23.60% |
Max Drawdown (10Y)Largest decline over 10 years | -59.29% | -82.89% | +23.60% |
Current DrawdownCurrent decline from peak | -45.77% | -76.34% | +30.57% |
Average DrawdownAverage peak-to-trough decline | -16.79% | -37.37% | +20.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.02% | 22.84% | -10.82% |
Volatility
WST vs. ALGN - Volatility Comparison
The current volatility for West Pharmaceutical Services, Inc. (WST) is 9.15%, while Align Technology, Inc. (ALGN) has a volatility of 13.28%. This indicates that WST experiences smaller price fluctuations and is considered to be less risky than ALGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| WST | ALGN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.15% | 13.28% | -4.13% |
Volatility (6M)Calculated over the trailing 6-month period | 24.91% | 27.12% | -2.21% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.43% | 54.36% | -12.93% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 40.04% | 49.37% | -9.33% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.27% | 48.79% | -14.52% |
Financials
WST vs. ALGN - Financials Comparison
This section allows you to compare key financial metrics between West Pharmaceutical Services, Inc. and Align Technology, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
WST vs. ALGN - Profitability Comparison
WST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, West Pharmaceutical Services, Inc. reported a gross profit of 303.90M and revenue of 805.00M. Therefore, the gross margin over that period was 37.8%.
ALGN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Align Technology, Inc. reported a gross profit of 683.59M and revenue of 1.05B. Therefore, the gross margin over that period was 65.3%.
WST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, West Pharmaceutical Services, Inc. reported an operating income of 157.10M and revenue of 805.00M, resulting in an operating margin of 19.5%.
ALGN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Align Technology, Inc. reported an operating income of 155.32M and revenue of 1.05B, resulting in an operating margin of 14.8%.
WST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, West Pharmaceutical Services, Inc. reported a net income of 132.10M and revenue of 805.00M, resulting in a net margin of 16.4%.
ALGN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Align Technology, Inc. reported a net income of 135.76M and revenue of 1.05B, resulting in a net margin of 13.0%.